These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27565300)

  • 1. High-fat, high-sugar, and high-cholesterol consumption does not impact tau pathogenesis in a mouse model of Alzheimer's disease-like tau pathology.
    Gratuze M; Julien J; Morin F; Calon F; Hébert SS; Marette A; Planel E
    Neurobiol Aging; 2016 Nov; 47():71-73. PubMed ID: 27565300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of voluntary treadmill exercise and caloric restriction on tau pathogenesis in a mouse model of Alzheimer's disease-like tau pathology fed with Western diet.
    Gratuze M; Julien J; Morin F; Marette A; Planel E
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):452-461. PubMed ID: 28779908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer's disease-like tau pathology.
    Gratuze M; Julien J; Petry FR; Morin F; Planel E
    Sci Rep; 2017 Apr; 7():46359. PubMed ID: 28402338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy.
    Graham DL; Gray AJ; Joyce JA; Yu D; O'Moore J; Carlson GA; Shearman MS; Dellovade TL; Hering H
    Neuropharmacology; 2014 Apr; 79():307-13. PubMed ID: 24326295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.
    Sepulveda-Diaz JE; Alavi Naini SM; Huynh MB; Ouidja MO; Yanicostas C; Chantepie S; Villares J; Lamari F; Jospin E; van Kuppevelt TH; Mensah-Nyagan AG; Raisman-Vozari R; Soussi-Yanicostas N; Papy-Garcia D
    Brain; 2015 May; 138(Pt 5):1339-54. PubMed ID: 25842390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAcylation: A regulator of tau pathology and neurodegeneration.
    Gong CX; Liu F; Iqbal K
    Alzheimers Dement; 2016 Oct; 12(10):1078-1089. PubMed ID: 27126545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
    Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Brain insulin signaling and Tau: impact for Alzheimer's disease and Tauopathies].
    Joly-Amado A; Gratuze M; Benderradji H; Vieau D; Buée L; Blum D
    Med Sci (Paris); 2018 Nov; 34(11):929-935. PubMed ID: 30526837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host Tau Genotype Specifically Designs and Regulates Tau Seeding and Spreading and Host Tau Transformation Following Intrahippocampal Injection of Identical Tau AD Inoculum.
    Andrés-Benito P; Carmona M; Jordán M; Fernández-Irigoyen J; Santamaría E; Del Rio JA; Ferrer I
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.
    Gatta E; Lefebvre T; Gaetani S; dos Santos M; Marrocco J; Mir AM; Cassano T; Maccari S; Nicoletti F; Mairesse J
    Pharmacol Res; 2016 Mar; 105():186-97. PubMed ID: 26816085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology?
    Muyllaert D; Kremer A; Jaworski T; Borghgraef P; Devijver H; Croes S; Dewachter I; Van Leuven F
    Genes Brain Behav; 2008 Feb; 7 Suppl 1():57-66. PubMed ID: 18184370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau aggregation in the hippocampal formation: an ageing or a pathological process?
    Delacourte A; Sergeant N; Wattez A; Maurage CA; Lebert F; Pasquier F; David JP
    Exp Gerontol; 2002; 37(10-11):1291-6. PubMed ID: 12470843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.
    Liu F; Iqbal K; Grundke-Iqbal I; Hart GW; Gong CX
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10804-9. PubMed ID: 15249677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice.
    Leboucher A; Laurent C; Fernandez-Gomez FJ; Burnouf S; Troquier L; Eddarkaoui S; Demeyer D; Caillierez R; Zommer N; Vallez E; Bantubungi K; Breton C; Pigny P; Buée-Scherrer V; Staels B; Hamdane M; Tailleux A; Buée L; Blum D
    Diabetes; 2013 May; 62(5):1681-8. PubMed ID: 23250356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the HDAC2/HNF-4A/miR-101b/AMPK Pathway Rescues Tauopathy and Dendritic Abnormalities in Alzheimer's Disease.
    Liu D; Tang H; Li XY; Deng MF; Wei N; Wang X; Zhou YF; Wang DQ; Fu P; Wang JZ; Hébert SS; Chen JG; Lu Y; Zhu LQ
    Mol Ther; 2017 Mar; 25(3):752-764. PubMed ID: 28202389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Evidence of Low Bone Density and Decreased Serotonergic Synthesis in the Dorsal Raphe of a Tauopathy Model of Alzheimer's Disease.
    Dengler-Crish CM; Smith MA; Wilson GN
    J Alzheimers Dis; 2017; 55(4):1605-1619. PubMed ID: 27814296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model.
    Julien C; Tremblay C; Phivilay A; Berthiaume L; Emond V; Julien P; Calon F
    Neurobiol Aging; 2010 Sep; 31(9):1516-31. PubMed ID: 18926603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of three-repeat isoforms of tau contributes to tau pathology in a rat model of chronic type 2 diabetes.
    Jung HJ; Park SS; Mok JO; Lee TK; Park CS; Park SA
    Exp Neurol; 2011 Apr; 228(2):232-41. PubMed ID: 21281635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology.
    Burlot MA; Braudeau J; Michaelsen-Preusse K; Potier B; Ayciriex S; Varin J; Gautier B; Djelti F; Audrain M; Dauphinot L; Fernandez-Gomez FJ; Caillierez R; Laprévote O; Bièche I; Auzeil N; Potier MC; Dutar P; Korte M; Buée L; Blum D; Cartier N
    Hum Mol Genet; 2015 Nov; 24(21):5965-76. PubMed ID: 26358780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.